Tissue Diagnostics: Technologies and Global Markets

Report Highlights

The global tissue diagnostics market should reach $6.4 billion by 2026 from $4.7 billion in 2021 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2021 to 2026.

Report Includes

• 107 data tables and 28 additional tables
• An overview of the global market for tissue diagnostic testing
• Estimation of the market size and analyses of the global market trends, with data from 2018 to 2020, estimates for 2021 with projection of CAGR through 2026
• Market share analysis of tissue diagnostic testing based on type, application, end user and geography
• Detailed description of the three major tissue diagnostics tests, i.e., hematoxylin and eosin (H&E), immunohistochemistry (IHC) and in situ hybridization (ISH)
• Description of molecular diagnostic tests including antigen tests, antibody (serology) tests and in vitro diagnostic testing, and information on alternative options for diagnostic tests
• Details about COVID-19 global pandemic, its testing basics and specific tests for the management of COVID-19 patients
• Identification of new opportunities, challenges and technological changes within the industry
• Assessment of regulatory structure, pricing and reimbursement scenario, pipeline analysis and FDA product approvals in 2020
• Company profiles of major players in the market, including Abbott Diagnostics Inc., Becton, Dickinson and Co., General Electric, Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.

Report Scope

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, South Korea, Taiwan, Africa, Australia, Brazil, and Russia, among others. The report also examines market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the industry through their best practices in the research and development of tissue diagnostic tests. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:

• Structure and current market size of the market for tissue diagnostics as outlined with forecasts through 2026.
• Impact of chronic diseases, growing and aging populations.
• Current technology and product suppliers and key innovations.
• A look at the trends affecting the market.
• Markets by each segment of type of test (general culture test, AST/ID tests and blood culture tests).
• A global overview showing market data for North America, Europe, Asia-Pacific and Rest of the World.
• Emerging opportunities and potential investment opportunity areas for tissue diagnostics.
• Profiles for more than 20 companies in the industry with significant contributions and market shares.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Global Electric Vehicle Battery Reuse and Recycling Market (FCB058B)
• Artificial Intelligence (AI) in Cancer (BIO196B)
• Nutraceuticals: Global Markets (FOD013J)
• Protective Relays and Circuit Breakers: Global Markets (IAS157B)
• Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)